{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T05:07:53Z","timestamp":1746076073988},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11064-023-03885-0","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T11:06:10Z","timestamp":1676286370000},"page":"1971-1980","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunosuppressant Tacrolimus Treatment Delays Acute Seizure Occurrence, Reduces Elevated Oxidative Stress, and Reverses PGF2\u03b1 Burst in the Brain of PTZ-Treated Rats"],"prefix":"10.1007","volume":"48","author":[{"given":"Burcu Azak","family":"Pazarlar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cansu Bilister","family":"Egilmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mumin Alper","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oytun","family":"Erbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"3885_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher RS, Acevedo C, Arzimanoglou A et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475\u2013482. https:\/\/doi.org\/10.1111\/epi.12550","journal-title":"Epilepsia"},{"key":"3885_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ncl.2016.06.015","volume":"34","author":"A Singh","year":"2016","unstructured":"Singh A, Trevick S (2016) The epidemiology of global epilepsy. Neurol Clin 34:837\u2013847. https:\/\/doi.org\/10.1016\/j.ncl.2016.06.015","journal-title":"Neurol Clin"},{"key":"3885_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMra1004418","volume":"365","author":"P Kwan","year":"2011","unstructured":"Kwan P, Schachter SC, Brodie MJ (2011) Drug-resistant epilepsy. N Engl J Med 365:919\u2013926. https:\/\/doi.org\/10.1056\/NEJMra1004418","journal-title":"N Engl J Med"},{"key":"3885_CR4","doi-asserted-by":"publisher","first-page":"105648","DOI":"10.1016\/j.nbd.2022.105648","volume":"165","author":"A Arulsamy","year":"2022","unstructured":"Arulsamy A, Shaikh MF (2022) Epilepsy-associated comorbidities among adults: a plausible therapeutic role of gut microbiota. Neurobiol Dis 165:105648. https:\/\/doi.org\/10.1016\/j.nbd.2022.105648","journal-title":"Neurobiol Dis"},{"key":"3885_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2165\/00003495-200059020-00021","volume":"59","author":"GL Plosker","year":"2000","unstructured":"Plosker GL, Foster RH (2000) Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 59:323\u2013389. https:\/\/doi.org\/10.2165\/00003495-200059020-00021","journal-title":"Drugs"},{"key":"3885_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00775-009-0597-2","volume":"15","author":"J Chwiej","year":"2010","unstructured":"Chwiej J, Janeczko K, Marciszko M et al (2010) Neuroprotective action of FK-506 (tacrolimus) after seizures induced with pilocarpine: quantitative and topographic elemental analysis of brain tissue. J Biol Inorg Chem 15:283\u2013289. https:\/\/doi.org\/10.1007\/s00775-009-0597-2","journal-title":"J Biol Inorg Chem"},{"key":"3885_CR7","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s11064-017-2221-0","volume":"42","author":"Y Wen","year":"2017","unstructured":"Wen Y, Fu P, Wu K et al (2017) Inhibition of calcineurin A by FK506 suppresses seizures and reduces the expression of GluN2B in membrane fraction. Neurochem Res 42:2154\u20132166. https:\/\/doi.org\/10.1007\/s11064-017-2221-0","journal-title":"Neurochem Res"},{"key":"3885_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00702-011-0746-y","volume":"119","author":"HJ Shin","year":"2012","unstructured":"Shin HJ, Jeon BT, Kim J et al (2012) Effect of the calcineurin inhibitor FK506 on K+-Cl- cotransporter 2 expression in the mouse hippocampus after kainic acid-induced status epilepticus. J Neural Transm (Vienna) 119:669\u2013677. https:\/\/doi.org\/10.1007\/s00702-011-0746-y","journal-title":"J Neural Transm (Vienna)"},{"key":"3885_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fncel.2017.00428","volume":"11","author":"J Liu","year":"2017","unstructured":"Liu J, Si Z, Li S et al (2017) The calcineurin inhibitor FK506 prevents cognitive impairment by inhibiting reactive astrogliosis in Pilocarpine-Induced Status Epilepticus rats. Front Cell Neurosci 11:428. https:\/\/doi.org\/10.3389\/fncel.2017.00428","journal-title":"Front Cell Neurosci"},{"key":"3885_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainres.2019.02.031","volume":"1715","author":"A Wang","year":"2019","unstructured":"Wang A, Si Z, Xue P et al (2019) Tacrolimus protects hippocampal neurons of rats with status epilepticus through suppressing oxidative stress and inhibiting mitochondrial pathway of apoptosis. Brain Res 1715:176\u2013181. https:\/\/doi.org\/10.1016\/j.brainres.2019.02.031","journal-title":"Brain Res"},{"key":"3885_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0168-0102(96)01036-x","volume":"25","author":"A Moriwaki","year":"1996","unstructured":"Moriwaki A, Lu YF, Hayashi Y et al (1996) Immunosuppressant FK506 prevents mossy fiber sprouting induced by kindling stimulation. Neurosci Res 25:191\u2013194. https:\/\/doi.org\/10.1016\/0168-0102(96)01036-x","journal-title":"Neurosci Res"},{"key":"3885_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/s0306-4522(98)00071-2","volume":"86","author":"A Moriwaki","year":"1998","unstructured":"Moriwaki A, Lu YF, Tomizawa K, Matsui H (1998) An immunosuppressant, FK506, protects against neuronal dysfunction and death but has no effect on electrographic and behavioral activities induced by systemic kainate. Neuroscience 86:855\u2013865. https:\/\/doi.org\/10.1016\/s0306-4522(98)00071-2","journal-title":"Neuroscience"},{"key":"3885_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.neures.2006.08.006","volume":"56","author":"T Nishimura","year":"2006","unstructured":"Nishimura T, Imai H, Minabe Y et al (2006) Beneficial effects of FK506 for experimental temporal lobe epilepsy. Neurosci Res 56:386\u2013390. https:\/\/doi.org\/10.1016\/j.neures.2006.08.006","journal-title":"Neurosci Res"},{"key":"3885_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.eplepsyres.2006.09.001","volume":"73","author":"Z Setkowicz","year":"2007","unstructured":"Setkowicz Z, Ciarach M (2007) Neuroprotectants FK-506 and cyclosporin a ameliorate the course of pilocarpine-induced seizures. Epilepsy Res 73:151\u2013155. https:\/\/doi.org\/10.1016\/j.eplepsyres.2006.09.001","journal-title":"Epilepsy Res"},{"key":"3885_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.eplepsyres.2018.01.007","volume":"140","author":"T-Q Xiong","year":"2018","unstructured":"Xiong T-Q, Chen L-M, Tan B-H et al (2018) The effects of calcineurin inhibitor FK506 on actin cytoskeleton, neuronal survival and glial reactions after pilocarpine-induced status epilepticus in mice. Epilepsy Res 140:138\u2013147. https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.01.007","journal-title":"Epilepsy Res"},{"key":"3885_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/s0091-3057(03)00160-6","volume":"75","author":"A Singh","year":"2003","unstructured":"Singh A, Kumar G, Naidu PS, Kulkarni SK (2003) Protective effect of FK506 (tacrolimus) in pentylenetetrazol-induced kindling in mice. Pharmacol Biochem Behav 75:853\u2013860. https:\/\/doi.org\/10.1016\/s0091-3057(03)00160-6","journal-title":"Pharmacol Biochem Behav"},{"key":"3885_CR17","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3389\/fneur.2019.00971","volume":"10","author":"A Wang","year":"2019","unstructured":"Wang A, Si Z, Li X et al (2019) FK506 attenuated pilocarpine-induced epilepsy by reducing inflammation in rats. Front Neurol 10:971. https:\/\/doi.org\/10.3389\/fneur.2019.00971","journal-title":"Front Neurol"},{"key":"3885_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/s0920-1211(01)00284-4","volume":"46","author":"K Suzuki","year":"2001","unstructured":"Suzuki K, Omura S, Ohashi Y et al (2001) FK506 facilitates chemical kindling induced by pentylenetetrazole in rats. Epilepsy Res 46:279\u2013282. https:\/\/doi.org\/10.1016\/s0920-1211(01)00284-4","journal-title":"Epilepsy Res"},{"key":"3885_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.neuroscience.2012.05.013","volume":"218","author":"S Takei","year":"2012","unstructured":"Takei S, Hasegawa-Ishii S, Uekawa A et al (2012) Immunohistochemical demonstration of increased prostaglandin F\u00e2\u201a\u201a\u03b1 levels in the rat hippocampus following kainic acid-induced seizures. Neuroscience 218:295\u2013304. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.05.013","journal-title":"Neuroscience"},{"key":"3885_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0006-8993(87)91360-6","volume":"404","author":"H Baran","year":"1987","unstructured":"Baran H, Heldt R, Hertting G (1987) Increased prostaglandin formation in rat brain following systemic application of kainic acid. Brain Res 404:107\u2013112. https:\/\/doi.org\/10.1016\/0006-8993(87)91360-6","journal-title":"Brain Res"},{"key":"3885_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0197-0186(95)00053-b","volume":"27","author":"MG Naffah-Mazzacoratti","year":"1995","unstructured":"Naffah-Mazzacoratti MG, Bell\u00edssimo MI, Cavalheiro EA (1995) Profile of prostaglandin levels in the rat hippocampus in pilocarpine model of epilepsy. Neurochem Int 27:461\u2013466. https:\/\/doi.org\/10.1016\/0197-0186(95)00053-b","journal-title":"Neurochem Int"},{"key":"3885_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00313153","volume":"222","author":"D Egg","year":"1980","unstructured":"Egg D, Herold M, Rumpl E, G\u00fcnther R (1980) Prostaglandin F2 alpha levels in human cerebrospinal fluid in normal and pathological conditions. J Neurol 222:239\u2013248. https:\/\/doi.org\/10.1007\/BF00313153","journal-title":"J Neurol"},{"key":"3885_CR23","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s11064-020-03101-3","volume":"45","author":"F Duranku\u015f","year":"2020","unstructured":"Duranku\u015f F, \u015eenkal E, S\u00fcnnet\u00e7i E et al (2020) Beneficial effects of ibuprofen on pentylenetetrazol-induced convulsion. Neurochem Res 45:2409\u20132416. https:\/\/doi.org\/10.1007\/s11064-020-03101-3","journal-title":"Neurochem Res"},{"key":"3885_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14728222.2019.1554056","volume":"23","author":"A Rojas","year":"2019","unstructured":"Rojas A, Chen D, Ganesh T et al (2019) The COX-2\/prostanoid signaling cascades in seizure disorders. Expert Opin Ther Targets 23:1\u201313. https:\/\/doi.org\/10.1080\/14728222.2019.1554056","journal-title":"Expert Opin Ther Targets"},{"key":"3885_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/0471142301.ns0937s58","author":"A Dhir","year":"2012","unstructured":"Dhir A (2012) Pentylenetetrazol (PTZ) kindling model of epilepsy. Curr Protoc Neurosci. https:\/\/doi.org\/10.1002\/0471142301.ns0937s58","journal-title":"Curr Protoc Neurosci"},{"key":"3885_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.peptides.2012.12.003","volume":"40","author":"O Erbas","year":"2013","unstructured":"Erbas O, Y\u0131lmaz M, Korkmaz HA et al (2013) Oxytocin inhibits pentylentetrazol-induced seizures in the rat. Peptides 40:141\u2013144. https:\/\/doi.org\/10.1016\/j.peptides.2012.12.003","journal-title":"Peptides"},{"key":"3885_CR27","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1179\/1743132814Y.0000000391","volume":"37","author":"O Erba\u015f","year":"2015","unstructured":"Erba\u015f O, Solmaz V, Aksoy D (2015) Inhibitor effect of dexketoprofen in rat model of pentylenetetrazol-induced seizures. Neurol Res 37:1096\u20131101. https:\/\/doi.org\/10.1179\/1743132814Y.0000000391","journal-title":"Neurol Res"},{"key":"3885_CR28","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s11064-021-03310-4","volume":"46","author":"A Erdogan","year":"2021","unstructured":"Erdogan A, Erdogan MA, Atasoy O, Erbas O (2021) Effects of the calcium channel blocker otilonium bromide on seizure activity in rats with pentylenetetrazole-induced convulsions. Neurochem Res 46:1717\u20131724. https:\/\/doi.org\/10.1007\/s11064-021-03310-4","journal-title":"Neurochem Res"},{"key":"3885_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281\u2013294. https:\/\/doi.org\/10.1016\/0013-4694(72)90177-0","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"3885_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1046\/j.1471-4159.2001.00426.x","volume":"78","author":"JE Kurz","year":"2001","unstructured":"Kurz JE, Sheets D, Parsons JT et al (2001) A significant increase in both basal and maximal calcineurin activity in the rat pilocarpine model of status epilepticus. J Neurochem 78:304\u2013315. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00426.x","journal-title":"J Neurochem"},{"key":"3885_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.nbd.2003.08.018","volume":"14","author":"JE Kurz","year":"2003","unstructured":"Kurz JE, Rana A, Parsons JT, Churn SB (2003) Status epilepticus-induced changes in the subcellular distribution and activity of calcineurin in rat forebrain. Neurobiol Dis 14:483\u2013493. https:\/\/doi.org\/10.1016\/j.nbd.2003.08.018","journal-title":"Neurobiol Dis"},{"key":"3885_CR32","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/mrm.10297","volume":"48","author":"K Kaneko","year":"2002","unstructured":"Kaneko K, Itoh K, Berliner LJ et al (2002) Consequences of nitric oxide generation in epileptic-seizure rodent models as studied by in vivo EPR. Magn Reson Med 48:1051\u20131056. https:\/\/doi.org\/10.1002\/mrm.10297","journal-title":"Magn Reson Med"},{"key":"3885_CR33","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1046\/j.1460-9568.2002.01947.x","volume":"15","author":"AP Kudin","year":"2002","unstructured":"Kudin AP, Kudina TA, Seyfried J et al (2002) Seizure-dependent modulation of mitochondrial oxidative phosphorylation in rat hippocampus. Eur J Neurosci 15:1105\u20131114. https:\/\/doi.org\/10.1046\/j.1460-9568.2002.01947.x","journal-title":"Eur J Neurosci"},{"key":"3885_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainres.2009.04.053","volume":"1281","author":"Y Jin","year":"2009","unstructured":"Jin Y, Lim C-M, Kim S-W et al (2009) Fluoxetine attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. Brain Res 1281:108\u2013116. https:\/\/doi.org\/10.1016\/j.brainres.2009.04.053","journal-title":"Brain Res"},{"key":"3885_CR35","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1007\/s43440-020-00143-w","volume":"72","author":"KK Borowicz-Reutt","year":"2020","unstructured":"Borowicz-Reutt KK, Czuczwar SJ (2020) Role of oxidative stress in epileptogenesis and potential implications for therapy. Pharmacol Rep 72:1218\u20131226. https:\/\/doi.org\/10.1007\/s43440-020-00143-w","journal-title":"Pharmacol Rep"},{"key":"3885_CR36","first-page":"88","volume":"12","author":"H Younus","year":"2018","unstructured":"Younus H (2018) Therapeutic potentials of superoxide dismutase. Int J Health Sci (Qassim) 12:88\u201393","journal-title":"Int J Health Sci (Qassim)"},{"key":"3885_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.brainres.2007.12.017","volume":"1193","author":"H-J Kim","year":"2008","unstructured":"Kim H-J, Chung J-I, Lee SH et al (2008) Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX-2 inhibitors. Brain Res 1193:153\u2013161. https:\/\/doi.org\/10.1016\/j.brainres.2007.12.017","journal-title":"Brain Res"},{"key":"3885_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/DNND.S240800","volume":"10","author":"H Famitafreshi","year":"2020","unstructured":"Famitafreshi H, Karimian M (2020) Prostaglandins as the agents that modulate the course of brain disorders. Degener Neurol Neuromuscul Dis 10:1\u201313. https:\/\/doi.org\/10.2147\/DNND.S240800","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"3885_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/nan.12444","volume":"44","author":"EA van Vliet","year":"2018","unstructured":"van Vliet EA, Aronica E, Vezzani A, Ravizza T (2018) Review: neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies. Neuropathol Appl Neurobiol 44:91\u2013111. https:\/\/doi.org\/10.1111\/nan.12444","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3885_CR40","doi-asserted-by":"publisher","first-page":"a022699","DOI":"10.1101\/cshperspect.a022699","volume":"6","author":"A Vezzani","year":"2015","unstructured":"Vezzani A, Lang B, Aronica E (2015) Immunity and inflammation in epilepsy. Cold Spring Harb Perspect Med 6:a022699. https:\/\/doi.org\/10.1101\/cshperspect.a022699","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3885_CR41","doi-asserted-by":"publisher","first-page":"14663","DOI":"10.1074\/jbc.M511089200","volume":"281","author":"K Yoshikawa","year":"2006","unstructured":"Yoshikawa K, Kita Y, Kishimoto K, Shimizu T (2006) Profiling of eicosanoid production in the rat hippocampus during kainic acid-induced seizure: dual phase regulation and differential involvement of COX-1 and COX-2. J Biol Chem 281:14663\u201314669. https:\/\/doi.org\/10.1074\/jbc.M511089200","journal-title":"J Biol Chem"},{"key":"3885_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1365-2125.1996.03804.x","volume":"42","author":"N Delanty","year":"1996","unstructured":"Delanty N, Reilly M, Pratico D et al (1996) 8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. Br J Clin Pharmacol 42:15\u201319. https:\/\/doi.org\/10.1046\/j.1365-2125.1996.03804.x","journal-title":"Br J Clin Pharmacol"},{"key":"3885_CR43","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1002\/rcm.4197","volume":"23","author":"NE Bastani","year":"2009","unstructured":"Bastani NE, Gundersen TE, Blomhoff R (2009) Determination of 8-epi PGF(2alpha) concentrations as a biomarker of oxidative stress using triple-stage liquid chromatography\/tandem mass spectrometry. Rapid Commun Mass Spectrom 23:2885\u20132890. https:\/\/doi.org\/10.1002\/rcm.4197","journal-title":"Rapid Commun Mass Spectrom"},{"key":"3885_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.expneurol.2013.08.014","volume":"249","author":"J-I Chung","year":"2013","unstructured":"Chung J-I, Kim AY, Lee SH, Baik EJ (2013) Seizure susceptibility in immature brain due to lack of COX-2-induced PGF2\u03b1. Exp Neurol 249:95\u2013103. https:\/\/doi.org\/10.1016\/j.expneurol.2013.08.014","journal-title":"Exp Neurol"},{"key":"3885_CR45","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3390\/antiox9111029","volume":"9","author":"T-K Lin","year":"2020","unstructured":"Lin T-K, Chen S-D, Lin K-J, Chuang Y-C (2020) Seizure-induced oxidative stress in status epilepticus: is antioxidant beneficial? Antioxidants (Basel) 9:1029. https:\/\/doi.org\/10.3390\/antiox9111029","journal-title":"Antioxidants (Basel)"},{"key":"3885_CR46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.15171\/apb.2017.035","volume":"7","author":"N Faghihi","year":"2017","unstructured":"Faghihi N, Mohammadi MT (2017) Anticonvulsant and antioxidant effects of pitavastatin against pentylenetetrazol-induced kindling in mice. Adv Pharm Bull 7:291\u2013298. https:\/\/doi.org\/10.15171\/apb.2017.035","journal-title":"Adv Pharm Bull"},{"key":"3885_CR47","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.brainresbull.2005.02.027","volume":"65","author":"A Ilhan","year":"2005","unstructured":"Ilhan A, Aladag MA, Kocer A et al (2005) Erdosteine ameliorates PTZ-induced oxidative stress in mice seizure model. Brain Res Bull 65:495\u2013499. https:\/\/doi.org\/10.1016\/j.brainresbull.2005.02.027","journal-title":"Brain Res Bull"},{"key":"3885_CR48","doi-asserted-by":"publisher","first-page":"e11541","DOI":"10.1590\/1414-431X2021e11541","volume":"54","author":"ES Bora","year":"2021","unstructured":"Bora ES, Karaali R, Akyol PY et al (2021) The effect of sulfasalazine in pentylenetetrazole-induced seizures in rats. Braz J Med Biol Res 54:e11541. https:\/\/doi.org\/10.1590\/1414-431X2021e11541","journal-title":"Braz J Med Biol Res"},{"key":"3885_CR49","first-page":"466","volume":"61","author":"A D\u0142ugosz","year":"2007","unstructured":"D\u0142ugosz A, Srednicka D, Boraty\u0144ski J (2007) [The influence of tacrolimus on oxidative stress and free-radical processes]. Postepy Hig Med Dosw (Online) 61:466\u2013471","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"3885_CR50","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ijpharm.2011.11.003","volume":"423","author":"AS Zidan","year":"2012","unstructured":"Zidan AS, Rahman Z, Sayeed V et al (2012) Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis. Int J Pharm 423:341\u2013350. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.11.003","journal-title":"Int J Pharm"},{"key":"3885_CR51","doi-asserted-by":"publisher","first-page":"E1926","DOI":"10.3390\/jcm9061926","volume":"9","author":"P Giza","year":"2020","unstructured":"Giza P, Ficek R, Dwulit T et al (2020) Number of regularly prescribed drugs and intrapatient tacrolimus trough levels variability in stable kidney transplant recipients. J Clin Med 9:E1926. https:\/\/doi.org\/10.3390\/jcm9061926","journal-title":"J Clin Med"},{"key":"3885_CR52","volume-title":"Tacrolimus","author":"AA Araya","year":"2022","unstructured":"Araya AA, Tasnif Y (2022) Tacrolimus. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"3885_CR53","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1016\/s0041-1345(01)02506-4","volume":"33","author":"AK Scheel","year":"2001","unstructured":"Scheel AK, Blaschke S, Schettler V et al (2001) Severe neurotoxicity of tacrolimus (FK506) after renal transplantation: two case reports. Transpl Proc 33:3693\u20133694. https:\/\/doi.org\/10.1016\/s0041-1345(01)02506-4","journal-title":"Transpl Proc"},{"key":"3885_CR54","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1093\/ndt\/14.10.2489","volume":"14","author":"P Grimbert","year":"1999","unstructured":"Grimbert P, Azema C, Pastural M et al (1999) Tacrolimus (FK506)-induced severe and late encephalopathy in a renal transplant recipient. Nephrol Dial Transplant 14:2489\u20132491. https:\/\/doi.org\/10.1093\/ndt\/14.10.2489","journal-title":"Nephrol Dial Transplant"},{"key":"3885_CR55","doi-asserted-by":"publisher","first-page":"685","DOI":"10.6002\/ect.2014.0204","volume":"14","author":"A Bican Demir","year":"2016","unstructured":"Bican Demir A, Erer \u00d6zbek S, Bora I et al (2016) Two cases with developing neurologic complications after liver transplant. Exp Clin Transplant 14:685\u2013687. https:\/\/doi.org\/10.6002\/ect.2014.0204","journal-title":"Exp Clin Transplant"},{"key":"3885_CR56","doi-asserted-by":"publisher","first-page":"e24989","DOI":"10.1097\/MD.0000000000024989","volume":"100","author":"Y Yang","year":"2021","unstructured":"Yang Y, Zhang L, Mo Y et al (2021) Tacrolimus-induced epilepsy with primary membranous nephropathy: a case report. Medicine (Baltimore) 100:e24989. https:\/\/doi.org\/10.1097\/MD.0000000000024989","journal-title":"Medicine (Baltimore)"},{"key":"3885_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ebcr.2018.01.002","volume":"10","author":"AS Vesole","year":"2018","unstructured":"Vesole AS, Nagahama Y, Granner MA et al (2018) Drug-resistant epilepsy development following stem cell transplant and cyclosporine neurotoxicity induced seizures: case report in an adult and analysis of reported cases in the literature. Epilepsy Behav Case Rep 10:8\u201313. https:\/\/doi.org\/10.1016\/j.ebcr.2018.01.002","journal-title":"Epilepsy Behav Case Rep"},{"key":"3885_CR58","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.braindev.2016.02.006","volume":"38","author":"Y Sato","year":"2016","unstructured":"Sato Y, Numata-Uematsu Y, Uematsu M et al (2016) Acute encephalitis with refractory, repetitive partial seizures: pathological findings and a new therapeutic approach using tacrolimus. Brain Dev 38:772\u2013776. https:\/\/doi.org\/10.1016\/j.braindev.2016.02.006","journal-title":"Brain Dev"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03885-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-023-03885-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03885-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T03:46:51Z","timestamp":1682048811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-023-03885-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3885"],"URL":"https:\/\/doi.org\/10.1007\/s11064-023-03885-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"assertion":[{"value":"18 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experimental procedures employed in the present study were approved by Animal Ethics Committee (Bilim University, Number: 03210203). Animals were provided by Bilim University, Istanbul, Turkey. All experiments were carried out according to the Guide for the Care and Use of Laboratory Animals, as confirmed by the National Institutes of Health (U.S.)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}